Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis

Lignende værker

• Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
  af: Alexeeva, E, et al.
  Udgivet: (2011)
• Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
  af: Horneff, G, et al.
  Udgivet: (2015)
• The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
  af: Goran, Ristic, et al.
  Udgivet: (2011)
• Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
  af: Quartier, P, et al.
  Udgivet: (2008)
• TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
  af: E.I. Alexeeva, et al.
  Udgivet: (2011-05-01)